We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
-2.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$90.4M
AUM Growth
-$22.6M
Cap. Flow
-$22.9M
Cap. Flow %
-25.37%
Top 10 Hldgs %
54.54%
Holding
219
New
11
Increased
7
Reduced
45
Closed
19

Sector Composition

Rank Sector Weight
1 Energy 21.56%
2 Financials 17.11%
3 Healthcare 15.96%
4 Consumer Staples 11.31%
5 Industrials 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
51
Conagra Brands
CAG
$7.42B
$138K 0.15%
4,044
-9,443
-70% -$283K
JNK icon
52
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.05B
$136K 0.15%
1,184
PEP icon
53
PepsiCo
PEP
$196B
$132K 0.15%
1,410
BDX icon
54
Becton Dickinson
BDX
$46.4B
$131K 0.14%
945
AMZN icon
55
Amazon
AMZN
$2.44T
$128K 0.14%
5,900
-2,600
-31% -$54.3K
XOM icon
56
ExxonMobil
XOM
$650B
$127K 0.14%
1,522
-12
-0.8% -$1.03K
ELV icon
57
Elevance Health
ELV
$81.5B
$121K 0.13%
735
CVX icon
58
Chevron
CVX
$382B
$118K 0.13%
1,220
ABB
59
DELISTED
ABB Ltd
ABB
$118K 0.13%
5,649
DUK icon
60
Duke Energy
DUK
$101B
$113K 0.13%
1,594
HUM icon
61
Humana
HUM
$43.9B
$109K 0.12%
570
AWK icon
62
American Water Works
AWK
$27B
$108K 0.12%
2,225
-5,075
-70% -$267K
REMX icon
63
VanEck Rare Earth/Strategic Metals ETF
REMX
$1.91B
$108K 0.12%
+1,612
New +$127K
XPH icon
64
State Street SPDR S&P Pharmaceuticals ETF
XPH
$481M
$103K 0.11%
1,646
RDS.A
65
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$101K 0.11%
1,770
+18
+1% +$1.1K
PFE icon
66
Pfizer
PFE
$143B
$86K 0.1%
2,698
THC icon
67
Tenet Healthcare
THC
$22.2B
$85K 0.09%
1,468
MCD icon
68
McDonald's
MCD
$193B
$84K 0.09%
884
APH icon
69
Amphenol
APH
$185B
$80K 0.09%
5,548
-20,000
-78% -$287K
FRAK
70
DELISTED
VanEck Vectors Unconventional Oil & Gas ETF
FRAK
$79K 0.09%
382
IP icon
71
International Paper
IP
$22.6B
$73K 0.08%
1,626
VWO icon
72
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$73K 0.08%
1,783
MRK icon
73
Merck
MRK
$322B
$72K 0.08%
1,326
PH icon
74
Parker-Hannifin
PH
$120B
$69K 0.08%
590
TT icon
75
Trane Technologies
TT
$98.8B
$67K 0.07%
1,000

Similar funds

Dunvegan Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Dunvegan Associates held 219 positions worth $90.4M, down 20% from $113M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Dunvegan Associates withdrew a net $22.9M in Q2 2015, closing 19 positions and reducing 45 holdings. Its most notable exit was Chicago Bridge & Iron Nv, an estimated $1.85M position sold in full.

By sector, the portfolio is most concentrated in Energy at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Dunvegan Associates opened a new position in VanEck Rare Earth/Strategic Metals ETF worth $108K.

  • Dunvegan Associates's largest Q2 2015 buy was VanEck Rare Earth/Strategic Metals ETF: 1,612 shares worth $108K.
  • Dunvegan Associates added most to iShares MSCI South Korea ETF in Q2 2015, an estimated $456K increase.
  • Dunvegan Associates's biggest Q2 2015 reduction was Mastercard, cutting an estimated $1.17M.
  • Dunvegan Associates fully exited Chicago Bridge & Iron Nv in Q2 2015, selling an estimated $1.85M.
  • Dunvegan Associates's ten largest holdings make up 55% of its $90.4M portfolio in Q2 2015.
  • Dunvegan Associates opened 11 new positions and closed 19 in Q2 2015.
  • Dunvegan Associates's portfolio value fell 20% quarter-over-quarter to $90.4M.

Based on Dunvegan Associates's 13F filing for Q2 2015, filed 28 Apr 2017.